Skip to main content

MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ: MLTX )

46.76 +0.34 (+0.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist

Other Filings

Form NT 10-K
Source: SEC/Edgar
March 28, 2013
Form 8-K
Source: SEC/Edgar
March 17, 2013
Form 10-Q/A
Source: SEC/Edgar
March 11, 2013
Form NT 10-Q
Source: SEC/Edgar
November 13, 2012
Form 8-K
Source: SEC/Edgar
October 30, 2012
Form DEF 14A
Source: SEC/Edgar
September 19, 2012
Form NT 10-Q
Source: SEC/Edgar
August 13, 2012
Form 8-K
Source: SEC/Edgar
July 05, 2012
Form NT 10-Q
Source: SEC/Edgar
May 15, 2012
Form NT 10-K
Source: SEC/Edgar
April 01, 2012
Form 8-K
Source: SEC/Edgar
March 25, 2012
Form 8-K
Source: SEC/Edgar
February 15, 2012
Form 8-K
Source: SEC/Edgar
February 13, 2012
Form 8-K
Source: SEC/Edgar
December 20, 2011
Form RW
Source: SEC/Edgar
December 18, 2011
Form D
Source: SEC/Edgar
November 21, 2011
Form NT 10-Q
Source: SEC/Edgar
November 13, 2011
Form 8-K
Source: SEC/Edgar
November 13, 2011
Form 8-K
Source: SEC/Edgar
October 05, 2011
Form 8-K
Source: SEC/Edgar
September 26, 2011
Form 8-K
Source: SEC/Edgar
August 31, 2011
Form DEFR14A
Source: SEC/Edgar
August 02, 2011
Form 8-K
Source: SEC/Edgar
July 31, 2011
Form DEF 14A
Source: SEC/Edgar
July 28, 2011
Form 8-K
Source: SEC/Edgar
June 27, 2011
Form 8-K
Source: SEC/Edgar
June 19, 2011
Form 8-K
Source: SEC/Edgar
June 05, 2011
Form 8-K
Source: SEC/Edgar
May 24, 2011
Form 8-K
Source: SEC/Edgar
April 19, 2011
Form NT 10-K
Source: SEC/Edgar
March 30, 2011
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.